Most advertised drugs on U.S. TV 2022

Rinvoq, Dupixent, and Skyrizi were the top three most advertised drugs on U.S. TV in 2022 based on ad spend. Rinvox led the pack with more than 315.8 million U.S. dollars in TV ad expenditures that year, while Dupixent and Skyrizi spent 305.9 and 174.4 million, respectively. Pharmaceutical marketing and advertising As well as being advertised on TV, the pharmaceutical sector is actively promoted in medical and surgical journals. Advertising revenues generated via this medium reach well over 300 million U.S. dollars each year. By far, the largest amounts are devoted to advertising of antineoplastic agents – medicines used in cancer treatment. Bronchial steroids, antivirals, monoclonal antibodies and oral anticoagulants close the list of most advertised drug classes in health journals. On average, pharma companies allocated some nine million U.S. dollars to their marketing budgets in 2021, representing a growth of roughly 2.2 percent over the preceding year. Compared to other types of health care companies, pharmaceutical manufacturers had the largest marketing budgets and the majority of pharma executives also indicated that their marketing allowances were set to increase.

在2022年，基于广告支出，Rinvoq、Dupixent和Skyrizi位居美国电视广告中最多被宣传的药物前三位。Rinvoq以超过3.158亿美元的电视广告支出领跑，而Dupixent和Skyrizi的支出分别为3.059亿和1.744亿美元。除了在电视上做广告，制药行业亦在医学和外科期刊中积极推广。通过这一媒介产生的广告收入每年高达3亿美元以上。迄今为止，大部分资金被投入到抗肿瘤药物——用于癌症治疗的药物——的广告宣传中。支气管类固醇、抗病毒药物、单克隆抗体和口服抗凝剂则构成了健康期刊中最受广告宣传的药物类别。在2021年，制药公司平均将约900万美元投入到营销预算中，相较于上一年增长了大约2.2%。与其他类型的医疗保健公司相比，制药制造商拥有最大的营销预算，并且大多数制药高管也表示，他们的营销预算将有所增加。